Ascletis Pharma Inc. (ASCLF)
OTCMKTS · Delayed Price · Currency is USD
2.100
+0.120 (6.06%)
At close: Feb 10, 2026
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of $2.29 billion as of February 12, 2026. Its market cap has increased by 331.89% in one year.
Market Cap
2.29B
Enterprise Value
2.03B
Revenue
329.99K
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.10
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has increased from 2.00B to 2.29B, an increase of 14.35%. That is a compound annual growth rate of 1.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 2.29B | 58.28% |
| Dec 31, 2025 | 1.44B | 286.31% |
| Dec 31, 2024 | 373.84M | 91.83% |
| Dec 29, 2023 | 194.88M | -70.51% |
| Dec 30, 2022 | 660.87M | 44.13% |
| Dec 31, 2021 | 458.51M | 12.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.62M |
| CytoDyn | 317.38M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 104.83M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |